Switala, Lauren
Di, Lin
Gao, Huiyun
Asase, Courteney
Klos, Matthew
Rengasamy, Palanivel
Fedyukina, Daria
Maiseyeu, Andrei
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL130516)
American Heart Association (898722)
Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University (UL1TR002548)
Article History
Received: 23 January 2024
Accepted: 17 April 2024
First Online: 3 May 2024
Declarations
:
: All procedures involving animals were in compliance with the ethical principles established by the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 8523, revised 2011). The animal research protocol was approved by the Institutional Animal Care and Use Committee (IACUC) of Case Western Research University (Protocol No. 2016-0273).
: The authors consent for Nanobiotechnology to publish this work upon acceptance.
: Lauren Switala, Lin Di, and Andrei Maiseyeu hold a patent application (WO2023009790A1) filed by Case Western Reserve University entitled "Compositions and methods of promoting accumulation of therapeutic and diagnostic agents in the heart".